1. Salmeterol Xinafoate (in Fixed-Dose Combination with Fluticasone Propionate)

7. Pharmacokinetics (Absorption, Distribution, Metabolism, Excretion): Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.

16a. Renal Considerations: Renal: No dose adjustment needed. Hepatic: Both salmeterol and fluticasone undergo extensive hepatic CYP3A4 clearance; monitor closely in moderate-to-severe liver disease.

16b. Hepatic Considerations: Renal: No dose adjustment needed. Hepatic: Both salmeterol and fluticasone undergo extensive hepatic CYP3A4 clearance; monitor closely in moderate-to-severe liver disease.

• Oropharyngeal candidiasis (thrush) and hoarseness of voice (fluticasone has high topical potency and throat deposition if a spacer and mouth rinse are not used), fine tremor, palpitations, headache, muscle cramps.
• Increased incidence of bacterial Pneumonia in elderly COPD patients (particularly with the high 500 mcg fluticasone strength), systemic steroid effects (adrenal suppression, cataracts, osteoporosis), hypokalaemia, arrhythmias in IHD patients, paradoxical bronchospasm.

• Potent CYP3A4 Inhibitors (Ritonavir, Ketoconazole, Itraconazole, Clarithromycin): STRICTLY AVOID! Ritonavir and itraconazole increase plasma Fluticasone levels >100-fold (causing severe Cushing's syndrome and adrenal crisis) and increase Salmeterol levels (causing QTc prolongation and ventricular arrhythmias)
• Non-selective beta-blockers antagonise salmeterol
• Diuretics/theophylline increase hypokalaemia

15. Use in Special Populations (Pregnancy, Lactation, Paediatrics, Geriatrics): Evaluate maternal-foetal benefit-risk ratio, paediatric mg/kg ceiling, and geriatric renal function prior to prescribing.

17. Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.

• Patient Counselling Checklist: 1. Warn every patient on Seroflo: 'Seroflo is your slow-acting 12-hour daily shield—it takes 20 minutes to start working, so NEVER puff extra Seroflo during a sudden breathless attack! Keep your blue Asthalin inhaler handy for sudden rescue.' 2. Note that pMDI requires 2 puffs to deliver 50 mcg salmeterol (with a 30–60 second pause between puff 1 and puff 2), whereas Rotacaps require 1 capsule inside the Rotahaler. 3. Always rinse mouth, gargle, and spit water after every use!
• Meal & Clock Timing Instruction: Inhaled: Independent of food; rinse mouth and spit after every dose. (Strictly twice daily (every 12 hours: morning and night).)
• Missed Dose Protocol: Take the next scheduled dose at the normal time; never take extra puffs of Seroflo for acute breathlessness.
• Geriatric Dispensing Pearl: In elderly COPD patients using high-strength Seroflo 250 or 500, watch closely for recurrent lower respiratory infections/pneumonia, oral thrush, cataracts, and easy skin bruising; verify if the chest physician can step down steroid dose or use LAMA/LABA dual bronchodilation if eosinophils are low.

Storage & Dispensing Notes: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Seroflo pMDI Inhaler: Salmeterol 25 mcg + Fluticasone Propionate 125 mcg or 250 mcg per puff; Seroflo Rotacaps / Autohaler / Accuhaler (DPI): Salmeterol 50 mcg + Fluticasone Propionate 100 mcg, 250 mcg, or 500 mcg